Lifecare Valuation
LIFE Stock | NOK 14.20 0.75 5.58% |
At this time, the firm appears to be fairly valued. Lifecare AS secures a last-minute Real Value of 13.85 per share. The latest price of the firm is 14.2. Our model forecasts the value of Lifecare AS from analyzing the firm fundamentals such as Profit Margin of (0.77) %, current valuation of 215.17 M, and Return On Equity of -0.96 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Lifecare's price fluctuation is somewhat reliable at this time. Calculation of the real value of Lifecare AS is based on 3 months time horizon. Increasing Lifecare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lifecare stock is determined by what a typical buyer is willing to pay for full or partial control of Lifecare AS. Since Lifecare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lifecare Stock. However, Lifecare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 14.2 | Real 13.85 | Hype 14.2 | Naive 13.31 |
The intrinsic value of Lifecare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Lifecare's stock price.
Estimating the potential upside or downside of Lifecare AS helps investors to forecast how Lifecare stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lifecare more accurately as focusing exclusively on Lifecare's fundamentals will not take into account other important factors: Lifecare Total Value Analysis
Lifecare AS is now expected to have takeover price of 215.17 M with market capitalization of 306.45 M, debt of 2.7 M, and cash on hands of 11.48 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Lifecare fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
215.17 M | 306.45 M | 2.7 M | 11.48 M |
Lifecare Asset Utilization
One of the ways to look at asset utilization of Lifecare is to check how much profit was generated for every dollar of assets it reports. Lifecare AS secures a negative usage of assets of -0.47 %, losing 0.004657 for each kroner of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each kroner of assets it secures. Strictly speaking, asset utilization of Lifecare AS shows how discouraging it operates for each kroner spent on its assets.Lifecare Ownership Allocation
Lifecare AS maintains a total of 117.87 Million outstanding shares. Lifecare AS holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Lifecare Profitability Analysis
Net Loss for the year was (15.88 M) with profit before overhead, payroll, taxes, and interest of 1.6 M.About Lifecare Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Lifecare AS. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Lifecare AS based exclusively on its fundamental and basic technical indicators. By analyzing Lifecare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Lifecare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lifecare. We calculate exposure to Lifecare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lifecare's related companies.Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company was founded in 2006 and is headquartered in Bergen, Norway. LIFECARE is traded on Oslo Stock Exchange in Norway.
8 Steps to conduct Lifecare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lifecare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lifecare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Lifecare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Lifecare's revenue streams: Identify Lifecare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Lifecare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Lifecare's growth potential: Evaluate Lifecare's management, business model, and growth potential.
- Determine Lifecare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lifecare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Lifecare Stock
Lifecare financial ratios help investors to determine whether Lifecare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifecare with respect to the benefits of owning Lifecare security.